window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : January 20, 2026

  • News
  • About Us
Contact Us

Cell & Gene Therapy

  • Biotech,Cell & Gene Therapy,Clinical Development,Clinical Trials,Opthalmology,Rare Diseases,Research & Development

    AAVantgarde completes enrollment in LUCE-1 Phase 1 and Phase 2 trial of gene therapy AAVB-081 for Usher syndrome type 1B

    AAVantgarde Bio has completed enrollment in LUCE-1, a first-in-human Phase [...]

    January 16, 2026
  • Biologics & Biosimilars,Biotech,Cell & Gene Therapy,Clinical Development,Healthcare leadership,Movers & Shakers,Pharmaceuticals and therapeutics

    iXCells names Steve Smith CEO to advance human iPSC preclinical services

    iXCells Biotechnologies has appointed Steve Smith as chief executive officer, [...]

    January 14, 2026
  • Biologics & Biosimilars,Biotech,Cell & Gene Therapy,Healthcare leadership,Movers & Shakers,Pharmaceuticals and therapeutics

    NanoSyrinx appoints Thomas Farrell as CEO

    NanoSyrinx has appointed Thomas Farrell as chief executive officer and [...]

    January 14, 2026
  • Biotech,Cell & Gene Therapy,Genetic Diseases,Genomics and sequencing,Rare Diseases,Research & Development,Technology and platforms

    PacBio HiFi adopted to study sudden unexplained death in childhood and advance precision therapies for rare diseases

    PacBio is supporting two research initiatives that use its HiFi [...]

    January 13, 2026
  • CDMOs & Manufacturing,Cell & Gene Therapy,Clinical Development,Clinical Trials,Regulatory Affairs

    FDA clears IND amendment for automated manufacturing of Cabaletta’s rese-cel using Cellares platforms

    Cellares has secured FDA clearance of an IND amendment allowing [...]

    January 13, 2026
  • Biomanufacturing,Cell & Gene Therapy,Clinical Development,Drug Development,Technology and platforms

    Trenchant BioSystems confirms AutoCell platform can cut CGT manufacturing to 2.5 days

    Trenchant BioSystems has released internal and external data confirming its [...]

    January 12, 2026
  • Cell & Gene Therapy,Clinical Development,Clinical Trials,Oncology,Research & Development

    CERo reports early safety signals and platelet transfusion-free interval in Phase 1 AML trial

    CERo Therapeutics has reported early clinical findings from its ongoing [...]

    January 9, 2026
  • Biomanufacturing,Cell & Gene Therapy,Research & Development,Technology and platforms

    FUJIFILM Biosciences unveils new name and broad life sciences focus

    FUJIFILM Irvine Scientific has officially rebranded as FUJIFILM Biosciences, signalling [...]

    January 5, 2026
  • Biotech,CDMOs & Manufacturing,Cell & Gene Therapy,Clinical Development,European biotech,Partnerships & Funding

    eXmoor and UCL partner to accelerate academic cell and gene therapy programmes

    eXmoor Pharma has formed a strategic collaboration with University College [...]

    December 3, 2025
  • Cell & Gene Therapy,Clinical studies,Clinical Trials,Events and Conferences,Hematology,Oncology,Pharmaceuticals and therapeutics

    CytoAgents to present new CTO1681 clinical safety data at ASH annual meeting

    CytoAgents will present new clinical safety data for CTO1681 at [...]

    December 3, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Cereno Scientific publishes first peer-reviewed data on HDAC inhibitor CS014 showing antithrombotic effects without bleeding risk
    Categories: Biotech, Clinical Development, Drug Development, European biotech, Hematology, Research & Development, Respiratory
  • SPT Labtech adds automated Twist Bioscience NGS library preparation workflows to firefly platform
    Categories: Data Management, Genomics and sequencing, Research & Development, Technology and platforms
  • Almirall to launch phase 3 LumiNE study of lebrikizumab in nummular eczema
    Categories: Clinical Trials, Dermatology, Drug Development, European biotech, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top